Durvalumab (MEDI4736) Plus Platinum-based Chemotherapy in Advanced LCNEC: a Pilot Phase II Study

Clinical trial NCT05262985 · UNKNOWN

Trial details

NCT number: NCT05262985
Sponsor: Elizabeth Dudnik
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Patients With Advanced Treatment Naive LCNEC

Start date: 2022-01-31
Primary completion: 2024-01-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.